Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report
暂无分享,去创建一个
Jing Han | Z. Fan | J. Zuo | Yudong Wang | Long Wang | Danyang Li | Xue Zhang | Jiayin Liu | Li Feng | H. Jin